Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
855 Diacylglycerol kinase alpha and zeta dual inhibitors enhance T cell responses and promote robust and durable anti-tumor T cell immunity
Compose a Response to This Article
Other responses
No responses have been published for this article.